These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1725911)

  • 21. [Restenosis after PTCA].
    Heidland UE; Michel CJ; Heintzen MP; Strauer BE
    Dtsch Med Wochenschr; 1998 Jul; 123(27):840-6. PubMed ID: 9685844
    [No Abstract]   [Full Text] [Related]  

  • 22. The Frankfurt experience in restenosis after coronary angioplasty.
    Bussmann WD; Kaltenbach M; Kober G; Vallbracht C
    Am J Cardiol; 1987 Jul; 60(3):48B-49B. PubMed ID: 2956842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of beta-adrenergic blockers after percutaneous transluminal coronary angioplasty.
    Johansson SR; Lamm C; Bondjers G; Emanuelsson H; Hjalmarson A
    Am J Cardiol; 1990 Oct; 66(12):915-20. PubMed ID: 1977297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of diltiazem on complications and restenosis after coronary angioplasty.
    O'Keefe JH; Giorgi LV; Hartzler GO; Good TH; Ligon RW; Webb DL; McCallister BD
    Am J Cardiol; 1991 Feb; 67(5):373-6. PubMed ID: 1994661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of recombinant hirudin (CGP 39,393/TMREVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty. Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study.
    Herrman JP; Simon R; Umans VA; Peerboom PF; Keane D; Rijnierse JJ; Bach D; Kobi P; Kerry R; Close P
    Eur Heart J; 1995 Nov; 16 Suppl L():56-62. PubMed ID: 8869020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of calcium antagonists on long-term survival of patients treated with coronary angioplasty.
    Kanzaki H; Miyazaki S; Noguchi T; Yasuda S; Sumida H; Daikoku S; Morii I; Itoh A; Goto Y; Nonogi H
    Jpn Heart J; 1999 Jan; 40(1):11-21. PubMed ID: 10370393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty.
    Hillegass WB; Ohman EM; Leimberger JD; Califf RM
    Am J Cardiol; 1994 May; 73(12):835-9. PubMed ID: 8184803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic effects of calcium channel blockers on restenosis.
    Thaulow E
    J Cardiovasc Pharmacol; 1999; 33 Suppl 2():S12-6. PubMed ID: 10071258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty.
    Whitworth HB; Roubin GS; Hollman J; Meier B; Leimgruber PP; Douglas JS; King SB; Gruentzig AR
    J Am Coll Cardiol; 1986 Dec; 8(6):1271-6. PubMed ID: 2946740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical promise of calcium antagonists in the angioplasty patient.
    Thaulow E; Jörgensen B
    Eur Heart J; 1997 May; 18 Suppl B():B21-6. PubMed ID: 9152666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.
    Vahanian A; Lung B
    Drugs; 1996; 52 Suppl 4():9-15; discussion 15-6. PubMed ID: 8913714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?
    Schneider W; Kober G; Roebruck P; Noack H; Alle M; Cieslinski G; Reifart N; Kaltenbach M
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S17-23. PubMed ID: 2261941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical approaches to prevention of restenosis after coronary angioplasty.
    Blackshear JL; O'Callaghan WG; Califf RM
    J Am Coll Cardiol; 1987 Apr; 9(4):834-48. PubMed ID: 2951423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance and predisposing factors to symptomatic bradycardia and hypotension after percutaneous transluminal coronary angioplasty.
    Mager A; Strasberg B; Rechavia E; Birnbaum Y; Mazur A; Yativ N; Sclarovsky S
    Am J Cardiol; 1994 Dec; 74(11):1085-8. PubMed ID: 7977063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of restenosis after coronary angioplasty: a pharmacological approach.
    Meier B
    Eur Heart J; 1989 Dec; 10 Suppl G():64-8. PubMed ID: 2697565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part I).
    Herrman JP; Hermans WR; Vos J; Serruys PW
    Drugs; 1993 Jul; 46(1):18-52. PubMed ID: 7691506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can the progression of coronary sclerosis be influenced by calcium antagonists?
    Kober G; Schneider W; Kaltenbach M
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S2-6. PubMed ID: 2475678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of restenosis after PTCA: role of calcium antagonists.
    Hoberg E; Kübler W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S15-9. PubMed ID: 1725911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium-antagonists in preventing restenosis following coronary angioplasty.
    Hoberg E; Kübler W
    Cardiologia; 1991 Dec; 36(12 Suppl 1):225-7. PubMed ID: 1841774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Calcium antagonists and prevention of post-angioplasty restenosis].
    Hoberg E
    Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():29-34. PubMed ID: 7503622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.